Dominic Edelmann - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Dominic Edelmann

Showing results (41-50 of 45) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 45 results.

Journal of Hematology & Oncology|August 16, 2023

Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual diseaseJonas S Heitmann, Richard F Schlenk, Daniela Dörfel, et al.

NPJ Precision Oncology|December 15, 2025

Benchmarking progression-free survival ratio as primary endpoint in precision oncology clinical trialsFederico Nichetti, Jennifer Hüllein, Pauline du Rusquec, et al.

International Journal of Cancer|August 4, 2023

Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patientsHanla A Park, Dominic Edelmann, Federico Canzian, et al.

Acta Neuropathologica|March 23, 2021

TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymomaChristian Thomas, Felix Thierfelder, Malte Träger, et al.

Blood Cancer Discovery|February 6, 2025

Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell LymphomaNora Liebers, Ariane Boumendil, Hervé Finel, et al.

Pageof 5

Search research articles

Showing results (41-50 of 45) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 45 results.

Journal of Hematology & Oncology|August 16, 2023

Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual diseaseJonas S Heitmann, Richard F Schlenk, Daniela Dörfel, et al.

NPJ Precision Oncology|December 15, 2025

Benchmarking progression-free survival ratio as primary endpoint in precision oncology clinical trialsFederico Nichetti, Jennifer Hüllein, Pauline du Rusquec, et al.

International Journal of Cancer|August 4, 2023

Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patientsHanla A Park, Dominic Edelmann, Federico Canzian, et al.

Acta Neuropathologica|March 23, 2021

TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymomaChristian Thomas, Felix Thierfelder, Malte Träger, et al.

Blood Cancer Discovery|February 6, 2025

Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell LymphomaNora Liebers, Ariane Boumendil, Hervé Finel, et al.

Pageof 5